Shire Blocks Par From Selling Adderall Generic
A New Jersey federal judge signed off Tuesday on a permanent injunction barring Par Pharmaceutical Inc. from selling a generic version of Shire LLC's attention deficit hyperactivity disorder medication Adderall XR....To view the full article, register now.
Already a subscriber? Click here to view full article